Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease

Journal of Neural Transmission

Volumn 105, Issue 4-5, 1998, Pages 423-438

  Frolich L ^a,b   Blum Degen, D ^b   Bernstein, H G ^c   Engelsberger, S ^b   Humrich, J ^b   Laufer, S ^b   Muschner, D ^b   Thalheimer, A ^b   Turk A ^b   Hoyer, S ^d   Zochling R ^e   Boissl, K W ^e   Jellinger, K ^f   Riederer, P ^b  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e NÖ Landesnervenklinik ^*  (Austria)

^f LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Aging; Alzheimer's disease; Insulin; Insulin receptor

Indexed keywords

BRAIN RECEPTOR; C PEPTIDE; INSULIN; INSULIN ANTIBODY; INSULIN RECEPTOR; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEOCORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RECEPTOR DENSITY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; BRAIN; C-PEPTIDE; FRONTAL LOBE; HUMANS; INSULIN; MIDDLE AGED; NEURONS; OCCIPITAL LOBE; PARIETAL LOBE; RECEPTOR, INSULIN; REFERENCE VALUES; TEMPORAL LOBE;

EID: 15444339756     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050068     Document Type: Article

References (69)

1. Araujo DM, Lapchak PA, Collier B, Chabot JG, Quirion R (1989) Insulin-like growth factor-I (somatomedin-C) receptors in the rat brain: distribution and interaction with the hippocampal cholinergic system. Brain Res 484: 130-138
2. Baskin DG, Wilcox BJ, Figlewicz DP, Dorsa DM (1988) Insulin and insulin-like growth factors in the CNS. Trends Neurosci 11: 107-111
3. Beal MF, Uhl G, Mazurek MF, Kowall N, Martin GB (1986) Somatostatin: alterations in the central nervous system in neurological disorders. In: Martin GB, Barchas JD (eds) Neuropeptides in neurological and psychiatric disease. Raven, New York, pp 215-257
4. Becker AB, Roth RA (1990) Insulin receptor structure and function in normal and pathological conditions. Ann Rev Med 41: 99-115
5. Bernstein H-G, Müller M (1995) Increased immunostaining for L-ornithine decarboxylase occurs in neocortical neurons of Alzheimer's disease patients. Neurosci Lett 186: 123-126
6. Bessmann SP, Mohan C, Zaidise I (1986) Intracellular site of insulin action: mitochondrial Krebs cycle. Biochemistry 83: 5067-5070
7. Blum-Degen D, Frölich L, Hoyer S, Riederer P (1995) Altered brain glucose metabolism as a cause of neurodegenerative disorders? J Neural Transm [Suppl] 46: 139-147
8. Bowen DM, Smith AB, White P, Davison AN, Goodhart MJ, Curzon G, Iwangoff P, Mayer-Ruge W (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99: 459-496
9. Bowen DM, White P, Spillane JA, Goodhart MJ, Curzon G, Iwangoff P, Mayer-Ruge W, Davison AN (1979) Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet i: 11-14
10. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
11. Calissano P, Ciotti MT, Battistini L, Zona C, Angelini A, Merlo D, Mercanti D (1993) Recombinant insulin-like growth factor I exerts a trophic action and confers glutamate sensitivity on glutamate-resistant cerebellar cells. Proc Natl Acad Sci USA 90: 8752-8756
12. Chalmers DT, Dewar D, Graham DI, Brooks DN, McCulloch J (1990) Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type. Proc Natl Acad Sci USA 87: 1352-1356
13. Crews FT, McElhaney R, Freund G, Ballinger WEJ, Raizada MK (1992) Insulin-like growth factor I receptor binding in brains of Alzheimer's and alcoholic patients. J Neurochem 58: 1205-1210
14. Cullen KM, Halliday GM, Double KL, Brooks WS, Creasey H, Broe GA (1997) Cell loss in the nucleus basalis is related to regional cortical atrophy in Alzheimer's disease. Neuroscience 78: 641-652
15. DeKayser J, Wilczak N, Goosens A (1994) Insulin-like growth factor-1 receptor densities in human frontal cortex and white matter during aging, in Alzheimer's disease, and in Huntington's disease. Neurosci Lett 172: 93-96
16. dePablo F, de la Rosa E (1995) The developing CNS: a scenario for the action of proinsulin, insulin and insulin-like growth factors. Trends Neurosci 18: 143-150
17. Desoye G, Schmon B, Gmoser G, Friedl H, Urdl W, Weiss PAM (1992a) Insulin binding to erythrocytes of nonpregnant women: a reevaluation, underlining the importance of body weight even in nonobese subjects. Clin Chim Acta 207: 57-71
18. Devaskar SU, Giddings SJ, Rajakumar PA, Carnaghi LR, Menon RK, Zahm DS (1994) Insulin gene expression and insulin synthesis in mammalian neuronal cells. J Biol Chem 269: 8445-8454
19. Dorn A, Ziegler M, Bernstein H-G, Dietz H, Rinne A (1983) Introducing a monoclonal antibody to insulin: the islets of Langerhans as a model for immunohistochemistry. Acta Histochem 73: 293-295
20. Dorn A, Ziegler M, Bernstein H-G, Dietz H, Rinne A (1984) Concerning the presence of insulin-related peptide in the human brain: an immunohistochemical reinvestigation by use of monoclonal insulin antibodies. Acta Histochem 74: 81-84
21. Ferrier IN, Cross AJ, Johnson JA, Roberts GW, Crow TJ, Corsellis JA, Lee YC, O'Shaughnessy D, Adrian TE, McGregor GP, et al (1983) Neuropeptides in Alzheimer type dementia. J Neurol Sci 62: 159-170
22. Frölich L, Weinmueller M, Barth N, Goetz N, Dirr A, Gsell W, Jellinger K, Beckmann H, Riederer P (1997) (r)-, but not (s)-alpha lipoic acid stimulates deficient brain pyruvate dehydrogenase complex in vascular dementia, but not in Alzheimer dementia. Arch Gerontol Geriatr (in press)
23. Fukuyama H, Ogawa M, Yamauchi H, Yamaguchi S, Kimura J, Yonekura Y, Konishi J (1994) Altered cerebral energy metabolism in Alzheimer's disease: a PET study. J Nucl Med 35: 1-6
24. Gibson GE, Sheu KF, Blass JP, Baker A, Carlson KC, Harding B, Perrino P (1988) Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch Neurol 45: 836-840
25. Gsell W, Moll G, Sofic E, Riederer P (1993) Cholinergic and monoaminergic neurotransmitter systems in patients with Alzheimer's disease and senile dementia of Alzheimer type: a critical evaluation. In: Maurer K (ed) Dementias: neurochemistry, neuropathology, neuroimaging, neuropsychology and genetics. Vieweg, Braunschweig, pp 25-51
26. Gsell W, Lange KW, Reuffer R, Heckers S, Heinsen H, Senitz D, Jellinger K, Ransmayr G, Wichart I, Vock R, Beckmann H, Riederer P (1993) How to run a brain bank. A report from the Austro-German brain bank. J Neural Transm [Suppl] 39: 31-70
27. Havrankova J, Roth J (1978a) Insulin receptors are widely distributed in the central nervous system of the rat. Nature 272: 827-829
28. Havrankova J, Schmechel D, Roth J, Brownstein M (1978b) Identification of insulin in rat brain. Proc Natl Acad Sci USA 75: 5737-5741
29. Haxby JV, Grady CL, Duara R, Schlageter N, Berg G, Rapoport SI (1986) Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's type dementia. Arch Neurol 43: 882-885
30. Henneberg N, Hoyer S (1994) Short-term or long-term intracerebroventricular (i.c.v.) infusion of insulin exhibits a discrete anabolic effect on cerebral energy metabolism in the rat. Neurosci Lett 175: 153-156
31. Henneberg N, Hoyer S (1995) Desensitisation of the neuronal insulin receptor: a new approach in the etiopathogenesis of late-onset sporadic dementia of the Alzheimer type. Arch Gerontol Geriatr 21: 63-74
32. Herholz K (1995) FDG PET and differential diagnosis of dementia. Alzheimer Dis Assoc Disord 9: 6-16
33. Higgins GA, Mufson EJ (1989) NGF receptor gene expression is decreased in the nucleus basalis in Alzheimer's disease. Exp Neurol 106: 222-236
34. Hoyer S (1986) Senile dementia and Alzheimer's disease. Brain blood flow and metabolism. Prog Neuropsychopharmacol Biol Psychiatry 10: 447-478
35. Hoyer S (1996) Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease. Acta Neurol Scand [Suppl 165]: 18-24
36. Hoyer S, Oesterreich K, Wagner O (1988) Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type? J Neurol 235: 143-148
37. Hoyer S, Nitsch RM, Oesterreich K (1991) Predominant abnormality in cerebral glucose utilisation in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases. J Neural Transm [P-D Sect] 3: 1-14
38. Hoyer S, Prem L, Sorbi S, Amaducci L (1993) Stimulation of glycolytic key enzymes in cerebral cortex by insulin. Neuroreport 4: 991-993
39. Iwangoff P, Armbruster R, Enz A, Mayer-Ruge W (1980) Glycolytic enzymes from human autoptic brain cortex: normal aged and demented cases. Mech Ageing Dev 14: 203
40. Khachaturian Z (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42: 1097-1105
41. Knusel B, Michel PP, Schwaber JS, Hefti F (1990) Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. J Neurosci 10: 558-570
42. Kurochkin IV, Goto S (1994) Alzheimer's β-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett 345: 33-37
43. Kyriakis JM, Hausman RE, Peterson SW (1987) Insulin stimulates choline acetyltransferase activity in cultured embryonic chicken retina neurons. Proc Natl Acad Sci USA 84: 7463-7467
44. Lau C, Bartolome JV, Bartolome MB, Slotkin TA (1987) Central and sympathoadrenal responses to insulin in adult and neonatal rats. Dev Brain Res 36: 277-280
45. Marks JL, Porte D Jr, Stahl WL, Baskin DG (1990) Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology 127: 3234-3236
46. Massague J, Czech MP (1982) The subunit structure of two distinct receptors for insulin like growth factor I and II and their relationship to the insulin receptor. J Biol Chem 257: 5038-5045
47. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34: 939-944
48. Mill JF, Chao MV, Ishi DN (1985) Insulin, insulin-like growth factor II, and nerve growth factor effects on tubulin mRNA levels and neurite formation. Proc Natl Acad Sci 82: 7126-7130
49. Moroo I, Yamada T, Makino H, Tooyama I, McGeer PL, McGeer EG, Hirayama K (1993) Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease. Acta Neuropathol 87: 343-348
50. Morrison LD, Bergeron C, Kish SJ (1993) Brain S-adenosylmethionine decarboxylase activity is increased in different areas in Alzheimer's disease. Neurosci Lett 154: 141-144
51. Nieuwenhuys R, Voogd J, van Huijzen C (1990) The human central nervous system. A synopsis and atlas. Springer, Berlin Heidelberg New York Tokyo
52. Perry EK, Perry RH, Tomlinson BE, Blessed G, Gibson PH (1980) Coenzyme A-acetylating enzymes in Alzheimer's disease: possible cholinergic "compartment" of pyruvate dehydrogenase. Neurosci Lett 18: 105-110
53. Polonsky KS, Rubenstein AH (1984) C-peptide as a measure of the secretion an hepatic extraction of insulin; pitfalls and limitations. Diabetes 33: 486-493
54. Pope A (1982) General introduction. Human brain dissection. NINCDS Publications, Baltimore
55. Potau N, Escofet MA, Martinez MC (1991) Ontogenesis of insulin receptors in human cerebral cortex. J Endocrinol Invest 14: 53-58
56. Puro D, Agardh E (1984) Insulin-mediated regulation of neuronal maturation. Science 225: 1170-1172
57. Quirion R, Araujo DM, Lapehak PA, Seto D, Chabot JG (1991) Growth factors and lymphokines: modulators of cholinergic neuronal activity. Can J Neurol Sci 18: 390-393
58. Riederer P, Sofic E, Moll G, Freyberger A, Wichart I, Gsell W, Jellinger K, Hebenstreit G, Youdim MBH (1990) Dementia of Alzheimer type and Parkinson's disease: neurochemical overlaps and specific differences. In: Dostert P, Riederer P, Strolin-Benedetti M, Roncucci R (eds) Early markers in Parkinson's and Alzheimer's disease. Springer, Wien New York, pp 221-232
59. Rijksen G, Staal GEJ (1992) Methodologies for the detection and nonradioactive assay of protein-tyrosine kinase activities in human brain and gliomas. Neuroprotocols 1: 201-206
60. Rotwein P (1991) Structure, evolution, expression and regulation of insulin-like growth factors I and II. Growth Factors 5: 3-18
61. Shapiro IP, Masliah E, Saitoh T (1991) Altered protein tyrosine phosphorylation in Alzheimer's disease. J Neurochem 56: 1154-1162
62. Steiner DF, Chan SJ, Welsh JM, Kwok SCM (1985) Structure and evolution of the insulin gene. Ann Rev Genet 19: 463-469
63. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ, White MF (1991) Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352: 73-77
64. Tierney MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P (1988) The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathological study of 57 cases. Neurology 38: 359-364
65. White MF, Kahn CR (1994) The insulin signalling system. J Biol Chem 269: 1-4
66. Wozniak M, Rydzewski B, Baker SP, Raizada MK (1993) The cellular and physiological actions of insulin in the central nervous system. Neurochem Int 22: 1-10
67. Wozniak M, Rydzewski B, Baker SP, Raizada MK (1993) The cellular and physiological actions of insulin in the central nervous system. Neurochem Int 22: 1-10
68. Yang JW, Raizada MK, Fellows RE (1981) Effect of insulin on cultured rat brain cells: Stimulation of ornithine decarboxylase activity. J Neurochem 36: 1050-1070
69. Young WS (1986) Periventricular hypothalamic cells in the rat brain contain insulin mRNA. Neuropeptides 8: 93-97